Coloplast Financial Statements From 2010 to 2026

CBHD Stock  EUR 65.64  1.40  2.18%   
Coloplast's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Coloplast's valuation are provided below:
Gross Profit
18.9 B
Profit Margin
0.143
Market Capitalization
14.8 B
Enterprise Value Revenue
5.4575
Revenue
27.9 B
There are over seventy-five available fundamental signals for Coloplast AS, which can be analyzed over time and compared to other ratios. Active traders should verify all of Coloplast AS prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Coloplast Total Revenue

20.3 Billion

Check Coloplast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coloplast's main balance sheet or income statement drivers, such as Interest Expense of 960 M, Selling General Administrative of 6.8 B or Total Revenue of 20.3 B, as well as many indicators such as . Coloplast financial statements analysis is a perfect complement when working with Coloplast Valuation or Volatility modules.
  
This module can also supplement various Coloplast Technical models . Check out the analysis of Coloplast Correlation against competitors.

Coloplast Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets58 B55.3 B24.8 B
Slightly volatile
Other Current Liabilities855 K900 KB
Slightly volatile
Total Current Liabilities7.4 B11.7 B6.7 B
Slightly volatile
Total Stockholder Equity21.7 B20.6 B10.2 B
Slightly volatile
Other LiabilitiesB2.8 B1.4 B
Slightly volatile
Retained Earnings18.6 B17.7 B9.3 B
Slightly volatile
Accounts PayableB1.7 B941.9 M
Slightly volatile
Cash454.5 M709.2 M653.7 M
Slightly volatile
Other Assets1.3 B2.2 B1.3 B
Slightly volatile
Net Receivables3.7 B5.4 B3.4 B
Slightly volatile
Good Will23.4 B22.3 B7.7 B
Slightly volatile
Short Term Investments290.8 M197.1 M369.1 M
Slightly volatile
Inventory2.5 B4.2 B2.3 B
Slightly volatile
Other Current Assets11.1 M11.7 M168.1 M
Slightly volatile
Total Liabilities36.4 B34.7 B14.6 B
Slightly volatile
Long Term InvestmentsM4.5 M8.3 M
Slightly volatile
Short and Long Term Debt6.1 B5.8 B2.3 B
Slightly volatile
Total Current Assets7.9 B12 B7.5 B
Slightly volatile
Short Term Debt753 M1.2 B751.7 M
Slightly volatile
Intangible Assets13.2 B12.6 B4.4 B
Slightly volatile
Common Stock173.5 M194.4 M213.4 M
Slightly volatile
Property Plant Equipment3.2 B4.8 B3.1 B
Slightly volatile
Non Current Assets Total45.4 B43.3 B17.2 B
Slightly volatile
Non Currrent Assets Other6.4 B7.3 B5.8 B
Slightly volatile
Non Current Liabilities Total24.1 B22.9 B7.6 B
Slightly volatile
Non Current Liabilities OtherM6.3 M18.7 M
Slightly volatile
Net Debt25.2 B24 B8.1 B
Slightly volatile
Common Stock Shares Outstanding236.7 M259.1 M218.6 M
Slightly volatile
Capital Lease Obligations575.7 M1.1 B439.6 M
Slightly volatile
Net Invested Capital47.8 B45.5 B18.8 B
Slightly volatile
Capital Stock241.4 M262.2 M222.3 M
Slightly volatile
Property Plant And Equipment Net5.7 B7.6 B4.8 B
Slightly volatile
Property Plant And Equipment Gross12.5 B15.3 B10.9 B
Slightly volatile

Coloplast Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative6.8 B11.6 B6.4 B
Slightly volatile
Total Revenue20.3 B31.1 B18.7 B
Slightly volatile
Gross Profit13.8 B21 B12.7 B
Slightly volatile
Other Operating Expenses35.8 M64.4 M36.9 M
Slightly volatile
Operating Income6.3 B8.4 B5.7 B
Slightly volatile
Net Income From Continuing Ops4.2 B5.8 B3.7 B
Slightly volatile
EBIT5.9 BB5.6 B
Slightly volatile
Research Development736.1 MB660.6 M
Slightly volatile
Cost Of Revenue6.5 B10.1 BB
Slightly volatile
Total Operating Expenses14 B22.7 B13 B
Slightly volatile
Income Before Tax5.4 B7.4 B4.8 B
Slightly volatile
Net Income Applicable To Common Shares3.9 B5.4 B3.7 B
Slightly volatile
Net Income4.2 B5.8 B3.7 B
Slightly volatile
Income Tax Expense1.2 B1.6 B1.1 B
Slightly volatile
Tax Provision1.4 B1.5 B1.2 B
Slightly volatile
Interest Income96.6 M92 M42 M
Slightly volatile
EBITDA6.9 B8.3 B6.3 B
Slightly volatile
Reconciled Depreciation937.6 M1.5 B835.1 M
Slightly volatile

Coloplast Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation794.1 M1.5 B746 M
Slightly volatile
Dividends Paid3.3 B5.4 BB
Slightly volatile
Capital Expenditures891 M1.5 B835.9 M
Slightly volatile
Total Cash From Operating Activities4.4 B3.2 B3.7 B
Slightly volatile
Net Income4.2 B5.8 B3.7 B
Slightly volatile
End Period Cash Flow482 M906.2 M455.3 M
Slightly volatile
Other Cashflows From Investing Activities43.2 M48.6 M53 M
Slightly volatile
Free Cash Flow2.5 B1.3 B2.7 B
Pretty Stable
Begin Period Cash Flow1.1 BB493.5 M
Slightly volatile
Other Non Cash Items51.8 M77 M46.1 M
Slightly volatile

Coloplast Fundamental Market Drivers

About Coloplast Financial Statements

Coloplast stakeholders use historical fundamental indicators, such as Coloplast's revenue or net income, to determine how well the company is positioned to perform in the future. Although Coloplast investors may analyze each financial statement separately, they are all interrelated. For example, changes in Coloplast's assets and liabilities are reflected in the revenues and expenses on Coloplast's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Coloplast AS. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue31.1 B20.3 B
Cost Of Revenue10.1 B6.5 B

Currently Active Assets on Macroaxis

Other Information on Investing in Coloplast Stock

Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.